Activist 13D/13G Filings - InMed Pharmaceuticals Inc. (INM)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2024-02-14
2:28 pm
Purchase		13GINMED PHARMACEUTICALS INC
INM		ARMISTICE CAPITAL LLC606,214
9.99%		440,529increase
(+265.88%)		View
2024-01-03
5:43 pm
Purchase		13GINMED PHARMACEUTICALS INC
INM		SABBY MANAGEMENT LLC524,972
11%		524,972increase
(New Position)		View
2023-02-14
12:58 pm
Purchase		13GINMED PHARMACEUTICALS INC
INM		ARMISTICE CAPITAL LLC165,685
9.99%		165,685increase
(New Position)		View
2022-02-04
3:29 pm
Purchase		13GINMED PHARMACEUTICALS INC
INM		Hudson Bay Capital Management LP559,944
3.81%		115,500increase
(+25.99%)		View
2021-02-09
4:05 pm
Purchase		13GINMED PHARMACEUTICALS INC
INM		Hudson Bay Capital Management LP444,444
5.97%		444,444increase
(New Position)		View
2021-01-20
11:11 am
Unchanged		13GINMED PHARMACEUTICALS INC
INM		Empery Asset Management LP444,444
4.99%		0
(Unchanged)		View
2020-11-18
10:08 am
Purchase		13GINMED PHARMACEUTICALS INC
INM		Empery Asset Management LP444,444
6.35%		444,444increase
(New Position)		View